A decreased frequency of CD39+ γδ T cells was observed in patients with inflammatory bowel disease compared with healthy controls, which was further supported by the suppression of CD39 expression in Crohn's disease by endogenous antisense.57, 62. The gene discussed is ENTPD1; the disease is inflammatory bowel disease.